Public disclosures

CLMT insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Raymond Paul C

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Sell
Filing details

SEC transaction code S

Common Stock, par value $0.01 per share · Direct ownership · Reported balance after transaction: 18973 · SEC code covers open-market or private transactions

2026-11-182026-11-20

≈ $303,100.00

10,000 shares/units

SEC 4Follow
Raymond Paul C

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Units · Derivative security · Direct ownership · Reported balance after transaction: 251 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.

2026-11-122026-11-16

251 shares/units

SEC 4Follow
Raymond Paul C

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 754 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.

2026-11-122026-11-16

754 shares/units

SEC 4Follow
Boss John G.

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Units · Derivative security · Direct ownership · Reported balance after transaction: 75 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.

2026-11-122026-11-16

75 shares/units

SEC 4Follow
Boss John G.

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 226 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.

2026-11-122026-11-16

226 shares/units

SEC 4Follow
Mawer Stephen P

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Units · Derivative security · Direct ownership · Reported balance after transaction: 285 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.

2026-11-122026-11-16

285 shares/units

SEC 4Follow
Mawer Stephen P

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 857 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.

2026-11-122026-11-16

857 shares/units

SEC 4Follow
Schumacher Amy M

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Units · Derivative security · Direct ownership · Reported balance after transaction: 228 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2027.

2026-11-122026-11-16

228 shares/units

SEC 4Follow
Schumacher Amy M

Director · Calumet, Inc. /DE

CLMT

Calumet, Inc. /DE

Equity grant or award
Filing details

SEC transaction code A

Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 685 · Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. · Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested.

2026-11-122026-11-16

685 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement